Partner Sites

Molecular Diagnostics

Researchers are now targeting clonal hematopoiesis and building new solutions to help make liquid biopsy a frontline defense in the fight against cancer.
|3 min read

Beyond the Blood Draw: Making Liquid Biopsy More Accurate, One Mutation at a Time

As liquid biopsy becomes a standard tool in oncology, distinguishing tumor signals from clonal hematopoiesis is essential for accurate results
byMatthew Oberley, MD, PhD
Thumbnail
Updated |5+ min read

Optimize Your Clinical Lab with Streamlined Molecular Workflows

Explore a hypothetical scenario demonstrating how integrated workflows have the potential to help enhance efficiency, accuracy, and patient care
byToday's Clinical Lab andThermo Fisher Scientific
Sponsored by
Among acute myeloid leukemia (AML) subtypes, acute promyelocytic leukemia (APL) is both clinically urgent and therapeutically promising.
Updated |2 min read

Streamlining Acute Promyelocytic Leukemia Diagnosis: The Case for a Unified PML-RARA Testing Solution

Detecting all PML-RARA fusion isoforms in a single assay could help simplify the diagnostic workflow for acute promyelocytic leukemia
byMeghana Malur, PhD
Extracellular vesicles are nanometer-sized particles shed into body fluids, including blood and urine, that carry molecular information relevant to understanding, diagnosing, and treating cancer, degenerative diseases, and conditions in regenerative medicine.
|2 min read

Seed Funding Drives Development of Benchtop Exosome System for Precision Medicine

Hands-off isolation technology delivers higher yield and quality of extracellular vesicles, enabling reproducible workflows for clinical research and diagnostics
byHermes Biosciences
Young scientist’s discovery of BMP-producing machinery opens new paths for treating neurodegenerative disease.
|4 min read

Researcher Who Solved a 50-Year Mystery Wins Science & SciLifeLab Prize

Scientist uncovers machinery that makes a molecule with protective effects against various disorders
byAmerican Association for the Advancement of Science
Prior to joining ADLM, Wells served for two years as CEO of the American College of Medical Genetics and Genomics (ACMG), and the ACMG Foundation for Genetic and Genomic Medicine (ACMGF).
|2 min read

ADLM Names Melanie J. Wells as CEO to Advance Innovation in Diagnostics

Wells will lead ADLM’s efforts to advance diagnostics, strengthen advocacy, and support laboratory professionals
byAssociation for Diagnostics and Laboratory Medicine
Breakthrough studies in hematopathology will be presented at the Association for Molecular Pathology (AMP) 2025 Annual Meeting & Expo, taking place November 11–15 in Boston.
|3 min read

New Research in Blood Cancer Diagnostics to Be Featured at AMP 2025

Studies reveal faster, more precise genetic testing tools for acute myeloid leukemia
byAssociation for Molecular Pathology
The study adds new evidence that brain-related biomarkers might play a useful role in monitoring recovery and guiding personalized care for young patients with concussion.
|2 min read

Blood Markers Linked to Post-Concussion Symptoms in Teens

Some concussion biomarkers show sex-specific differences
byWolters Kluwer Health
Addressing the complex biology of progression is a major challenge in managing MS patients.
|3 min read

Capturing the Elusive: Why Multi-Protein Biomarkers Tests Are the Future of Measuring MS Progression

Exploring how precision biomarkers can reveal hidden disease dynamics and drive a new standard of MS care
byFerhan Qureshi
The report examines key indicators across states, including new case rates, survival, early diagnosis, surgical treatment, screening participation, and insurance coverage for comprehensive biomarker testing.
|2 min read

New Report Highlights Opportunities to Improve Lung Cancer Outcomes Across the US

State of Lung Cancer 2025 identifies lessons from Delaware and other states to expand screening, increase biomarker testing coverage, and save lives
byToday's Clinical Lab andAmerican Lung Association
The team focused on over 70 common cancer-related genes and identified more than 3,400 unique mutations.
|2 min read

New Research Finds up to 5 percent of Americans Carry Genetic Mutations Associated with Cancer Risk

Results highlight the importance of routine cancer screenings, suggest genetic testing should go beyond high-risk groups
byCleveland Clinic
Page 8 of 107
456789101112

Sponsored

Social

Bridging Vision and Execution: A Candid Conversation on the Future of the Laboratory

Sponsored by
A clinician holds a AI chip surrounded by digital healthcare icons, representing the use of artificial intelligence in clinical diagnostics

Ensuring Compliance: How to Get AI Diagnostic Tools Approved for Clinical Practice

Sponsored by
Two researchers working in a diagnostic lab with advanced testing solutions

Cutting-Edge Gastrointestinal Pathogen Testing Technologies for Labs

Sponsored by
Screenshot

The Path to Absolute Quantification in Gene Expression

Sponsored by